vs
Holley Inc.（HLLY）与再鼎医药（ZLAB）财务数据对比。点击上方公司名可切换其他公司
Holley Inc.的季度营收约是再鼎医药的1.2倍（$155.4M vs $127.1M），再鼎医药同比增速更快（17.1% vs 11.0%），Holley Inc.自由现金流更多（$3.8M vs $-26.7M），过去两年再鼎医药的营收复合增速更高（20.8% vs -1.0%）
霍利性能产品是一家主营汽车性能升级配件的企业，总部位于肯塔基州鲍灵格林。该公司由乔治·霍利与厄尔·霍利在1896年创立于宾夕法尼亚州布拉福德，早年扎根密歇根州时，曾是底特律多家整车厂主要的化油器供应商。
再鼎医药是一家创新生物制药企业，专注于肿瘤、自身免疫性疾病、感染性疾病等领域创新疗法的研发、生产与商业化，核心市场覆盖大中华区，与全球多家头部生物科技企业合作，为存在未被满足医疗需求的患者提供治疗方案。
HLLY vs ZLAB — 直观对比
营收规模更大
HLLY
是对方的1.2倍
$127.1M
营收增速更快
ZLAB
高出6.1%
11.0%
自由现金流更多
HLLY
多$30.5M
$-26.7M
两年增速更快
ZLAB
近两年复合增速
-1.0%
损益表 — Q4 FY2025 vs Q4 FY2025
| 指标 | | |
|---|---|---|
| 营收 | $155.4M | $127.1M |
| 净利润 | $6.3M | — |
| 毛利率 | 46.8% | 51.0% |
| 营业利润率 | 12.7% | -54.6% |
| 净利率 | 4.1% | — |
| 营收同比 | 11.0% | 17.1% |
| 净利润同比 | 116.7% | — |
| 每股收益（稀释后） | $0.06 | $-0.05 |
绿色 = 该指标领先。财年不对齐时期间可能不同
8季度营收与利润趋势
并排季度历史对比，按日历期对齐，财年错位的公司也能正确匹配
营收HLLYZLAB
| Q4 25 | $155.4M | $127.1M | ||
| Q3 25 | $138.4M | $115.4M | ||
| Q2 25 | $166.7M | $109.1M | ||
| Q1 25 | $153.0M | $105.7M | ||
| Q4 24 | $140.1M | $108.5M | ||
| Q3 24 | $134.0M | $101.8M | ||
| Q2 24 | $169.5M | $100.1M | ||
| Q1 24 | $158.6M | $87.1M |
净利润HLLYZLAB
| Q4 25 | $6.3M | — | ||
| Q3 25 | $-806.0K | $-36.0M | ||
| Q2 25 | $10.9M | $-40.7M | ||
| Q1 25 | $2.8M | $-48.4M | ||
| Q4 24 | $-37.8M | — | ||
| Q3 24 | $-6.3M | $-41.7M | ||
| Q2 24 | $17.1M | $-80.3M | ||
| Q1 24 | $3.7M | $-53.5M |
毛利率HLLYZLAB
| Q4 25 | 46.8% | 51.0% | ||
| Q3 25 | 43.2% | 59.5% | ||
| Q2 25 | 41.7% | 60.6% | ||
| Q1 25 | 41.9% | 63.6% | ||
| Q4 24 | 45.6% | 61.5% | ||
| Q3 24 | 39.0% | 64.1% | ||
| Q2 24 | 41.5% | 64.9% | ||
| Q1 24 | 32.8% | 61.4% |
营业利润率HLLYZLAB
| Q4 25 | 12.7% | -54.6% | ||
| Q3 25 | 11.5% | -42.3% | ||
| Q2 25 | 16.5% | -50.3% | ||
| Q1 25 | 12.6% | -53.3% | ||
| Q4 24 | -20.7% | -62.6% | ||
| Q3 24 | 4.2% | -66.6% | ||
| Q2 24 | 16.4% | -76.0% | ||
| Q1 24 | 6.4% | -80.7% |
净利率HLLYZLAB
| Q4 25 | 4.1% | — | ||
| Q3 25 | -0.6% | -31.2% | ||
| Q2 25 | 6.5% | -37.3% | ||
| Q1 25 | 1.8% | -45.8% | ||
| Q4 24 | -27.0% | — | ||
| Q3 24 | -4.7% | -40.9% | ||
| Q2 24 | 10.1% | -80.2% | ||
| Q1 24 | 2.4% | -61.4% |
每股收益（稀释后）HLLYZLAB
| Q4 25 | $0.06 | $-0.05 | ||
| Q3 25 | $-0.01 | $-0.03 | ||
| Q2 25 | $0.09 | $-0.04 | ||
| Q1 25 | $0.02 | $-0.04 | ||
| Q4 24 | $-0.32 | $-0.09 | ||
| Q3 24 | $-0.05 | $-0.04 | ||
| Q2 24 | $0.14 | $-0.08 | ||
| Q1 24 | $0.03 | $-0.05 |
资产负债表与财务实力
最新季度各公司的流动性、杠杆与账面价值一览
| 指标 | | |
|---|---|---|
| 现金及短期投资手头流动性 | $37.2M | $689.6M |
| 总债务越低越好 | $516.1M | — |
| 股东权益账面价值 | $448.9M | $715.5M |
| 总资产 | $1.2B | $1.2B |
| 负债/权益比越低杠杆越低 | 1.15× | — |
8季度趋势，按日历期对齐
现金及短期投资HLLYZLAB
| Q4 25 | $37.2M | $689.6M | ||
| Q3 25 | $50.7M | $717.2M | ||
| Q2 25 | $63.8M | $732.2M | ||
| Q1 25 | $39.1M | $757.3M | ||
| Q4 24 | $56.1M | $779.7M | ||
| Q3 24 | $50.8M | $616.1M | ||
| Q2 24 | $53.1M | $630.0M | ||
| Q1 24 | $41.1M | $650.8M |
总债务HLLYZLAB
| Q4 25 | $516.1M | — | ||
| Q3 25 | $528.9M | — | ||
| Q2 25 | $543.3M | — | ||
| Q1 25 | $551.3M | — | ||
| Q4 24 | $545.4M | — | ||
| Q3 24 | $556.4M | — | ||
| Q2 24 | $556.1M | — | ||
| Q1 24 | $567.6M | — |
股东权益HLLYZLAB
| Q4 25 | $448.9M | $715.5M | ||
| Q3 25 | $439.7M | $759.9M | ||
| Q2 25 | $437.8M | $791.7M | ||
| Q1 25 | $424.6M | $810.8M | ||
| Q4 24 | $421.2M | $840.9M | ||
| Q3 24 | $458.7M | $667.7M | ||
| Q2 24 | $463.2M | $704.2M | ||
| Q1 24 | $444.9M | $762.2M |
总资产HLLYZLAB
| Q4 25 | $1.2B | $1.2B | ||
| Q3 25 | $1.2B | $1.2B | ||
| Q2 25 | $1.2B | $1.2B | ||
| Q1 25 | $1.1B | $1.2B | ||
| Q4 24 | $1.1B | $1.2B | ||
| Q3 24 | $1.2B | $985.3M | ||
| Q2 24 | $1.2B | $987.4M | ||
| Q1 24 | $1.2B | $988.4M |
负债/权益比HLLYZLAB
| Q4 25 | 1.15× | — | ||
| Q3 25 | 1.20× | — | ||
| Q2 25 | 1.24× | — | ||
| Q1 25 | 1.30× | — | ||
| Q4 24 | 1.29× | — | ||
| Q3 24 | 1.21× | — | ||
| Q2 24 | 1.20× | — | ||
| Q1 24 | 1.28× | — |
现金流与资本效率
扣除再投资后实际产生的现金。现金流比净利润更难造假
| 指标 | | |
|---|---|---|
| 经营现金流最新季度 | $6.2M | $-26.0M |
| 自由现金流经营现金流 - 资本支出 | $3.8M | $-26.7M |
| 自由现金流率自由现金流/营收 | 2.4% | -21.0% |
| 资本支出强度资本支出/营收 | 1.5% | 0.5% |
| 现金转化率经营现金流/净利润 | 0.98× | — |
| 过去12个月自由现金流最近4个季度 | $33.9M | $-158.9M |
8季度趋势，按日历期对齐
经营现金流HLLYZLAB
| Q4 25 | $6.2M | $-26.0M | ||
| Q3 25 | $7.4M | $-32.0M | ||
| Q2 25 | $40.5M | $-31.0M | ||
| Q1 25 | $-7.8M | $-61.7M | ||
| Q4 24 | $4.1M | $-55.8M | ||
| Q3 24 | $-1.7M | $-26.8M | ||
| Q2 24 | $25.7M | $-42.2M | ||
| Q1 24 | $18.8M | $-90.1M |
自由现金流HLLYZLAB
| Q4 25 | $3.8M | $-26.7M | ||
| Q3 25 | $5.3M | $-35.0M | ||
| Q2 25 | $35.7M | $-33.9M | ||
| Q1 25 | $-10.8M | $-63.2M | ||
| Q4 24 | $1.7M | $-58.4M | ||
| Q3 24 | $-3.5M | $-28.2M | ||
| Q2 24 | $24.3M | $-42.9M | ||
| Q1 24 | $17.6M | $-91.1M |
自由现金流率HLLYZLAB
| Q4 25 | 2.4% | -21.0% | ||
| Q3 25 | 3.8% | -30.4% | ||
| Q2 25 | 21.4% | -31.1% | ||
| Q1 25 | -7.1% | -59.9% | ||
| Q4 24 | 1.2% | -53.8% | ||
| Q3 24 | -2.6% | -27.7% | ||
| Q2 24 | 14.3% | -42.9% | ||
| Q1 24 | 11.1% | -104.5% |
资本支出强度HLLYZLAB
| Q4 25 | 1.5% | 0.5% | ||
| Q3 25 | 1.6% | 2.6% | ||
| Q2 25 | 2.9% | 2.6% | ||
| Q1 25 | 1.9% | 1.5% | ||
| Q4 24 | 1.7% | 2.4% | ||
| Q3 24 | 1.3% | 1.3% | ||
| Q2 24 | 0.8% | 0.7% | ||
| Q1 24 | 0.8% | 1.1% |
现金转化率HLLYZLAB
| Q4 25 | 0.98× | — | ||
| Q3 25 | — | — | ||
| Q2 25 | 3.73× | — | ||
| Q1 25 | -2.79× | — | ||
| Q4 24 | — | — | ||
| Q3 24 | — | — | ||
| Q2 24 | 1.50× | — | ||
| Q1 24 | 5.05× | — |
财务流量对比
营收 → 毛利润 → 营业利润 → 净利润流向图
业务分部营收拆解
HLLY
| Truck Off Road | $125.5M | 81% |
| Euro Import | $29.9M | 19% |
ZLAB
| Zejula | $56.0M | 44% |
| Other | $21.9M | 17% |
| Nuzyra | $16.0M | 13% |
| Optune | $11.9M | 9% |
| XACDURO | $10.7M | 8% |
| Qinlock | $9.7M | 8% |
| AUGTYRO | $836.0K | 1% |
